Researchers continue to excited about the medication , a innovative dual treatment showing significant outcomes in early trials for size loss . It acts by impacting several pathways : GLP-1 and GIP, https://maeeaej254676.blogoscience.com/47468059/a-new-prospect-for-weight-loss